PVI
PTLA

Pura Vida Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Pura Vida Investments’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-56,225
Closed -$1.95M – 140
2019
Q1 		$1.95M Buy
56,225
+6,225
+12% +$180K 0.28% 77
2018
Q4 		$976K Buy
+50,000
New +$1.03M 0.19% 52

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM

Pura Vida Investments's PTLA Position: Q2 2019 in Review

Pura Vida Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2019, closing a stake of 56,225 shares — an estimated $1.95M sold.

Pura Vida Investments first reported a position in PTLA in Q4 2018 and held it in 2 quarters. The position peaked at $1.95M in Q1 2019. 202 funds tracked by Wall St. Rank hold PTLA as of Q2 2019.

  • Pura Vida Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Pura Vida Investments sold 56,225 Portola Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1.95M.
  • Pura Vida Investments first reported a position in Portola Pharmaceuticals, Inc. in Q4 2018 and held it in 2 quarters.
  • Pura Vida Investments's Portola Pharmaceuticals, Inc. position peaked at $1.95M in Q1 2019.
  • 202 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2019.

Based on Pura Vida Investments's 13F filing for Q2 2019, filed 14 Aug 2019.